South and Central America Liposome Drug Delivery Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, and Others); Technology (Stealth Liposome Technology, Non-PEGylated Liposome Technology, DepoFoam Liposome Technology, and Lysolipid Thermally Sensitive Liposome (LTSL) Technology); Application (Fungal Diseases, Cancer Therapy, Pain Management, Viral Vaccines, and Photodynamic Therapy), and Country

No. of Pages: 118    |    Report Code: TIPRE00016262    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South and Central America Liposome Drug Delivery Market

1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        South and Central America Liposome Drug Delivery Market – By Product

1.3.2        South and Central America Liposome Drug Delivery Market – By Technology

1.3.3        South and Central America Liposome Drug Delivery Market – By Application

1.3.4        South and Central America Liposome Drug Delivery Market – By Geography

2.          South and Central America Liposome Drug Delivery Market – Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          South and Central America Liposome Drug Delivery Market – Market Landscape

4.1        Overview

4.2        PEST Analysis

4.2.1        Liposome Drug Delivery Market - South and Central America PEST Analysis

4.3        Expert Opinion

5.          South and Central America Liposome Drug Delivery Market - Key Market Dynamics

5.1        Market Drivers

5.1.1        Rising prevalence of Chronic Diseases

5.1.2        Growing Demand for Non-Invasive Drug Delivery Devices

5.1.3        Increasing R&D Expenditures in Pharmaceutical Companies

5.2        Market Restraints

5.2.1        High Cost Involved in Development of Drug Delivery Systems

5.3        Market Opportunities

5.3.1        Development of New Lipid Composition for Stability and Optimization of Drugs

5.4        Future Trends

5.4.1        Increasing Popularity of Liposomes in Drug Delivery

5.5        Impact Analysis

6.          Liposome Drug Delivery Market – South and Central America Analysis

6.1        South and Central America Liposome Drug Delivery Market Revenue Forecasts and Analysis

7.          South and Central America Liposome Drug Delivery Market Analysis and Forecasts To 2027 – By Product Overview

7.1        South and Central America Liposome Drug Delivery Market, By Product Type 2019 & 2027 (%)

7.1.1        South and Central America Liposome Drug Delivery Market Revenue and Forecasts to 2027, By Product Type (US$ Mn)

7.2        Liposomal Doxurubicin

7.2.1        Overview

7.2.2        South and Central America Liposome Drug Delivery Market Revenue and Forecast to 2027 (US$ Mn)

7.3        Liposomal Paclitaxel

7.3.1        South and Central America Liposomal Paclitaxel Market Revenue and Forecasts to 2027 (US$ Mn)

7.4        Liposomal Amphotericin B

7.4.1        overview

7.4.2        South and Central America Liposomal Amphotericin B forecast and market revenue

7.5        Others

7.5.1        overview

7.5.2        South and Central America Other Liposome Drug Delivery Market overview and forecast to 2027

8.          South and Central America Liposome Drug Delivery Market – By Technology

8.1        Overview

8.2        South and Central America Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)

8.3        Stealth Liposome Technology

8.3.1        Overview

8.3.2        South and Central America Stealth Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

8.4        Non-PEGylated Liposome Technology

8.4.1        Overview

8.4.2        South and Central America Non-PEGylated Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

8.5        DepoFoam Liposome Technology

8.5.1        Overview

8.5.2        South and Central America DepoFoam Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

8.6        Lysolipid Thermally Sensitive Liposome (LTSL) Technology

8.6.1        Overview

8.6.2        South and Central America Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.          South and Central America Liposome Drug Delivery Market – By Application

9.1        Overview

9.2        South and Central America Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)

9.3        Fungal Diseases

9.3.1        Overview

9.3.2        Fungal Diseases: South and Central America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.4        Cancer Therapy

9.4.1        Overview

9.4.2        Cancer Therapy: South and Central America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.5        Pain Management

9.5.1        Overview

9.5.2        Pain Management: South and Central America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.6        Viral Vaccine

9.6.1        Overview

9.6.2        Viral Vaccine: South and Central America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

9.7        Photodynamic Therapy

9.7.1        Overview

9.7.2        Photodynamic Therapy: South and Central America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

10.       South and Central America Liposome Drug Delivery Market – Geographic Analysis

10.1      South and Central America : Liposome Drug Delivery Market

10.1.1     Overview

10.1.2     South and Central America : Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.3     South and Central America Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.4     South and Central America Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.5     South and Central America Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.6     South and Central America : Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)

10.1.7     Brazil : Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1       Brazil: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2       Brazil:Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.7.3       Brazil: Liposome Drug Delivery market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.7.4       Brazil: Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.8     Argentina : Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1       Argentina: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2       Argentina :Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

10.1.8.3       Argentina: Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.8.4       Argentina: Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

11.       Impact Of COVID-19 Pandemic On South and Central America Liposome Drug Delivery Market

11.1      South and Central America : Impact Assessment of COVID-19 Pandemic

12.       Company Profiles

12.1      Takeda Pharmaceutical Company Limited

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.3      Novartis AG

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.5      Luye Pharma Group

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Johnson & Johnson Services, Inc.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Ipsen Pharma

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

13.       Appendix

13.1      About the Insight Partners

13.2      Word Index

LIST OF TABLES

Table 1.            R&D Investments by major pharmaceutical companies

Table 2.            South and Central America Liposome Drug Delivery Market Revenue and Forecasts To 2027, By Product Type (US$ Mn)

Table 3.            South and Central America Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 4.            South and Central America Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 5.            South and Central America Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 6.            Brazil  Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 7.            Brazil Liposome Drug Delivery market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 8.            Brazil Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 9.            Argentina  Liposome Drug Delivery Market, by Product – Revenue and Forecast to 2027 (USD Million)

Table 10.          Argentina  Liposome Drug Delivery Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 11.          Argentina Liposome Drug Delivery Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 12.          List of Abbreviation

 

LIST OF FIGURES

Figure 1.           Liposome Drug Delivery Market Segmentation

Figure 2.           South and Central America Liposome Drug Delivery Segmentation : By Region

Figure 3.           South and Central America Liposome Drug Delivery Market Overview;

Figure 4.           Others Segment Held Largest Share of Product Type in Liposome Drug Delivery Market

Figure 5.           Brazil  is Expected to Show Remarkable Growth During the Forecast Period.

Figure 6.           Liposome Drug Delivery Market - South and Central America PEST Analysis

Figure 7.           South and Central America Liposome Drug Delivery Market Impact Analysis of Driver and Restraints

Figure 8.           South and Central America Liposome Drug Delivery Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.           South and Central America Liposome Drug Deliverys Market, By Product Type 2019 & 2027 (%)

Figure 10.        South and Central America Liposomal Doxurubicin Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11.        South and Central America Liposomal Paclitaxel Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.        South and Central America Liposomal Amphotericin B market revenue and forecast to 2027

Figure 13.        South and Central America Other Liposome Drug Delivery Market overview and forecast to 2027

Figure 14.        South and Central America Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)

Figure 15.        South and Central America Stealth Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        South and Central America Non-PEGylated Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17.        South and Central America DepoFoam Liposome Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        South and Central America Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 19.        South and Central America Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)

Figure 20.        Fungal Diseases: South and Central America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Cancer Therapy: South and Central America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Pain Management: South and Central America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Viral Vaccine: South and Central America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Photodynamic Therapy: South and Central America Liposome Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)

Figure 25.        South and Central America : Liposome Drug Delivery Market, by Key Country – Revenue (2019) (USD Million)

Figure 26.        South and Central America Liposome Drug Delivery Market Revenue and Forecast to 2027 (USD Million)

Figure 27.        South and Central America : Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)

Figure 28.        Brazil : Liposome Drug Delivery market – Revenue and Forecast to 2027 (USD Million)

Figure 29.        Argentina  : Liposome Drug Delivery Market – Revenue and Forecast to 2027 (USD Million)

Figure 30.        Impact of COVID-19 Pandemic In South and Central America  Country Markets

 

 

The List of Companies - South and Central America Liposome Drug Delivery Market

  1. Takeda pharmaceutical company
  2. Novartis AG
  3. Ipsen pharma
  4. Celsion Inc
  5. Luye pharma group